PA
JNJ icon

Paralel Advisors’s Johnson & Johnson JNJ Stock Holding History

Paralel Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-179,100
Closed -$26.2M – 111
2024
Q2 		$26.2M Hold
179,100
– – 1.25% 19
2024
Q1 		$28.3M Hold
179,100
– – 1.3% 19
2023
Q4 		$28.1M Hold
179,100
– – 1.44% 18
2023
Q3 		$27.9M Hold
179,100
– – 1.54% 19
2023
Q2 		$29.6M Hold
179,100
– – 1.58% 18
2023
Q1 		$27.8M Hold
179,100
– – 1.56% 18
2022
Q4 		$31.6M Hold
179,100
– – 1.86% 16
2022
Q3 		$29.3M Hold
179,100
– – 2.05% 15
2022
Q2 		$31.8M Hold
179,100
– – 2.13% 14
2022
Q1 		$31.7M Hold
179,100
– – 1.76% 15
2021
Q4 		$30.6M Buy
+179,100
New +$29.3M 1.78% 15

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Paralel Advisors's JNJ Position: Q3 2024 in Review

Paralel Advisors sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 179,100 shares — an estimated $26.2M sold.

Paralel Advisors first reported a position in JNJ in Q4 2021 and held it in 11 quarters. The position peaked at $31.8M in Q2 2022. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Paralel Advisors reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • Paralel Advisors sold 179,100 Johnson & Johnson shares in Q3 2024, an estimated $26.2M.
  • Paralel Advisors first reported a position in Johnson & Johnson in Q4 2021 and held it in 11 quarters.
  • Paralel Advisors's Johnson & Johnson position peaked at $31.8M in Q2 2022.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Paralel Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.